首页 | 本学科首页   官方微博 | 高级检索  
     

烟雾吸入性急性肺损伤药物治疗的研究进展
引用本文:纵加强,韩志海. 烟雾吸入性急性肺损伤药物治疗的研究进展[J]. 国际呼吸杂志, 2021, 41(6): 459-463
作者姓名:纵加强  韩志海
作者单位:南方医科大学第二临床医学院,广州 510515;中国人民解放军总医院第六医学中心呼吸与危重症医学科,北京 100048
基金项目:军队后勤科研计划重点项目(BHJ16J011)。
摘    要:烟雾吸入性急性肺损伤是火灾中伤员死亡的独立危险因素及死亡的主要原因。烟雾中有毒、有害化学气体和微粒引起的吸入性肺损伤是火灾后住院患者伤残的重要原因。近十年来,烟雾吸入性急性肺损伤相关的急救药物有了显著进展。

关 键 词:烟雾吸入损伤  药物疗法  研究进展

Progress in pharmacotherapy of smoke inhalation-induced acute lung injury
Zong Jiaqiang,Han Zhihai. Progress in pharmacotherapy of smoke inhalation-induced acute lung injury[J]. International Journal of Respiration, 2021, 41(6): 459-463
Authors:Zong Jiaqiang  Han Zhihai
Affiliation:(The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Department of Pulmonary and Critical Care Medicine,the Sixth Medical Center of Chinese PLA General Hospital,Beijing 100048,China)
Abstract:Smoke inhalation-induced acute lung injury(SI-ALI)is an independent risk factor of death for burn patients in fires,which is also the main cause of death.SI-ALI,caused by toxic and harmful chemical gases and particulates,is an important cause of disability for hospitalized patients after fire hazard.And over the last decade,the life-saving medicines for SI-ALI have made significant progress.
Keywords:Smoke inhalation injury  Drug therapy  Research progress
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号